Tagged 'Valsartan'

In July 2018, several forms of valsartan (a heartburn drug) were recalled. Test results revealed a cancer-causing material in the drug, triggering the recall. […]

Blood pressure medications account for hundreds of millions of prescriptions yearly. They play a significant role in the fight against heart disease. But two […]

Nitrosamines are impurities found in some cured meats, vegetables and medications. These impurities could cause cancer if consumed in certain quantities over a long […]

NDMA (n-nitrosodimethylamine) is the probable human carcinogen behind a number of recent drug recalls. As of July 2020, NDMA has been found in blood […]

This week's Legal Look covers coronavirus-related changes to Zantac and Zofran multidistrict litigation (MDL). It also touches on a recent suggestion that certain blood […]

This post was contributed to ConsumerSafety.org by Kate Harveston. The heart is the organ that keeps us going day in and day out. But, […]

This edition of Legal Look features Johnson & Johnson's latest court loss in a talc-related mesothelioma trial, an update on the NY Child Victims […]

The generic versions of losartan and valsartan made national headlines this past year when the FDA announced a significant number of recalls after finding […]

Last week brought a shocking new discovery to the year-long saga of generic blood pressure medication recalls. The online pharmaceutical retailer Valisure reportedly found […]

Valsartan is not the only sartan-based blood pressure medication to raise concerns in recent months. Since the U.S. Food and Drug Administration (FDA) started […]

In this issue of the Legal Look, we are covering a would-be Roundup class action lawsuit in Wisconsin that was denied certification, the expansion […]

In today's Legal Look, we're reviewing the acceptance of a revised $78 million verdict in the first Roundup lawsuit, the dismissal of a class […]